Celgene, Novartis File Ritalin Patent Suit
Pharmaceutical companies Celgene Corp. and Novartis AG continue to fight back against attempts to market a generic time-release version of Ritalin, a drug used to treat attention deficit/hyperactive disorder....To view the full article, register now.
Already a subscriber? Click here to view full article